← Back to all trials
Enrolling By Invitation
NCT07332416
Pilot Study of Continuous Glucose Monitoring for Postpartum Glucose Screening
Conditions: Gestational Diabetes
Sex: Female
Ages: 18 Years – N/A
Healthy volunteers: No
Phase: NA
Enrollment: 1300
Sponsor: Wake Forest University Health Sciences
Location: Wake Forest University Health Sciences Winston-Salem North Carolina
Summary
The oral glucose tolerance test (OGTT) is the standard of care in the postpartum period to screen patients with gestational diabetes mellitus (GDM) for persistent dysglycemia. However, most patients find it burdensome and dread having to do it. Adherence rates are low (18-61%), impeding initiation of follow-up care to improve diabetes-related outcomes in subsequent pregnancies and long-term.
Eligibility Criteria
Inclusion Criteria:
* 12-16 weeks postpartum
* Gestational diabetes Mellitus (GDM) diagnosis in most recent pregnancy
* Oral Glucose Tolerance Test (OGTT) order placed in the medical record
Exclusion Criteria:
* Pre-gestational diabetes
* Non-English language
Source: ClinicalTrials.gov (NCT07332416). StuddyBuddy aggregates publicly available trial information.
